IMMUNE-MEDIATED MYOCARDITIS FOLLOWING SINGLE DOSE OF ADJUVANT ATEZOLIZUMAB: DOES BENEFIT OUTWEIGH RISK?Ashwin S. Kumar, Ana Barac, Alexander A. Rizk et al.|Journal of the American College of Cardiology|2023Cited by 1
SEX BASED DIFFERENCES IN DETERMINING OUTCOMES OF RECURRENT PERICARDITISAshwin Kumar, Allan L. Klein, Abdullah Yesilyaprak et al.|Journal of the American College of Cardiology|2023Cited by 1